What should I do if alanine aminotransferase is low?
Alanine aminotransferase (ALT) is the most common indicator in liver function tests. A low level requires appropriate treatment based on the underlying cause, which may include dietary factors, viral hepatitis, pneumonia, fatty liver disease, cirrhosis, and others.
1. Dietary factors
If protein intake is insufficient in daily diet, the liver may not receive enough amino acids, leading to impaired liver function and reduced alanine aminotransferase levels. However, there are usually no other physical discomforts, obvious pain, or jaundice. Special treatment is generally unnecessary. Increasing intake of protein-rich foods such as milk, eggs, and fish in the daily diet can help improve symptoms.
2. Viral hepatitis
Viral hepatitis may cause liver tissue fibrosis, reduce the number of hepatocytes, and thereby affect the secretion of alanine aminotransferase. Antiviral medications such as entecavir tablets, lamivudine tablets, or sofosbuvir tablets should be taken under medical guidance to control symptoms.
3. Pneumonia
Pneumonia may trigger systemic inflammatory responses that damage the liver, resulting in decreased alanine aminotransferase levels. Symptoms such as fatigue and drowsiness may also occur. It is recommended to use antibiotics such as amoxicillin capsules, ampicillin capsules, or potassium penicillin V capsules under medical supervision to eliminate infection and relieve symptoms.
4. Fatty liver
Excessive accumulation of fat within liver cells impairs liver function, leading to lower alanine aminotransferase levels, possibly accompanied by changes in body weight. It is advisable to follow medical advice and use medications such as coenzyme A for injection, silymarin tablets, or ursodeoxycholic acid capsules, which can help repair liver cells and alleviate symptoms.
5. Cirrhosis
Alanine aminotransferase is primarily found in hepatocytes. Cirrhosis typically causes liver tissue damage and a reduction in hepatocyte count, thus affecting ALT levels. Symptoms such as fatigue and loss of appetite may accompany this condition. It is recommended to take medications such as tenofovir disoproxil fumarate tablets, entecavir dispersible tablets, or lamivudine tablets under medical guidance to reduce further hepatocyte injury.
Patients are advised to undergo comprehensive evaluations at the hospital and, based on individual conditions, receive targeted treatments under the guidance of a physician.